Podcast Episodes
Back to Search
Episode 10: Mentoring and Sponsoring
Michelle Maskaly and Christen Harm host one of Pharm Exec's Emerging Pharma Leaders, Sabina Ewing, vice president of business technology for Pfizer, …
8 years, 5 months ago
Episode 9: 2018 PE Brands of the Year
Michelle Maskaly and Christen Harm host the entire Pharmaceutical Executive editorial team on this episode, as we each talk about our Brands of the Y…
8 years, 5 months ago
Episode 8: CFO Insights From the Field
Tim Sullivan, CFO of Apellis Pharmaceuticals, gives an inside look at what it takes to be the CFO of a development-stage biotech company, and what bu…
8 years, 6 months ago
Episode 7: Big-Event Insights
Pharm Exec editors discuss key takeaways from a variety of industry conferences that took place across the globe.
Leadership Tip by Julia Cheek, CEO o…
8 years, 6 months ago
Episode 6: The Pharma vs. Biotech Experience
Christen Harm and Michelle Maskaly interview Lara Sullivan, founder and president of SpringWorks Therapeutics, about the differences in working for l…
8 years, 7 months ago
Episode 5: Med Affairs Training
Dr. William Soliman shares the story of how the Accreditation Council for Medical Affairs went from an idea in his head to a training program today t…
8 years, 7 months ago
Episode 4: Outcomes-Based Contracting
In this episode, Michelle Maskaly and Christen Harm talk with Editor-in-Chief Lisa Henderson and European Editor Julian Upton about outcomes-based co…
8 years, 8 months ago
Episode 3: Pharma's Reputation
Michelle Maskaly and Christen Harm talk to Devyn Smith, chief strategy officer and head of operations for Sigilon Therapeutics on the topic of pharma…
8 years, 8 months ago
Episode 2: JPMorgan Healthcare Conference 2018
In this episode, Michelle Maskaly and Christen Harm speak with Marc O'Connor, chief operating officer at Curant Health, and Pharm Exec's Editor-in-Ch…
8 years, 9 months ago
Episode 1: 2018 Pharmaceutical Trends
In this podcast, Pharmaceutical Executive editors discuss the 2018 pharma trends, specifically biosimilars and eEnablement, and takeaways from the 20…
8 years, 9 months ago